Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Oct 20;55(10):705.
doi: 10.3390/medicina55100705.

A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin

Affiliations
Case Reports

A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin

Dohee Kim et al. Medicina (Kaunas). .

Abstract

Paraphilia is a complex psychological and psychiatric disorder that has been difficult to treat. Leuprorelin has been used as one of the therapeutic methods for paraphilia. Leuprorelin administration could change insulin resistance and accelerate bone loss. The case study in this work was a 59-year-old man who visited a hospital with the chief complaints of frotteuristic behaviors in public places, a continuous increase in sexual desire, and sexual molestation behavior that started in 2007. We injected leuprorelin (3.6 mg) intramuscularly every month for this patient with paraphilia and comorbidities of osteoporosis and hyperthyroidism. The clinical global impression (CGI), Sex Addiction Screening Test (SAST), Wilson Sex Fantasy Questionnaire (WSFQ), physical examination, and laboratory tests were performed. After 12 months of leuprorelin injection for paraphilia, we found a significant improvement in abnormal sexual behavior/desire without aggravation of osteoporosis/hyperthyroidism. Gonadotrophin-Releasing Hormone (GnRH) analogs could be used as alternative or supplementary treatment methods for paraphilia with osteoporosis/hyperthyroidism.

Keywords: hyperthyroidism; leuprorelin; osteoporosis; paraphilia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed Text Revision ed. (DSM-5) American Psychiatric Association; Washington, DC, USA: 2013.
    1. Ward T., Gannon T.A., Birgden A. Human Rights and the Treatment of Sex Offenders. Sex. Abus. J. Res. Treat. 2007;19:195–204. doi: 10.1177/107906320701900302. - DOI - PubMed
    1. The Ministry of Justice of Korea . Act on Pharmacological Treatment of Sex Offenders Sexual Impulses. The Ministry of Justice of Korea; Gwacheon, Korea: 2011.
    1. Koo K.C., Ahn J.H., Hong S.J., Lee J.W., Chung B.H. Effects of Chemical Castration on Sex Offenders in Relation to the Kinetics of Serum Testosterone Recovery: Implications for Dosing Schedule. J. Sex. Med. 2014;11:1316–1324. doi: 10.1111/jsm.12492. - DOI - PubMed
    1. Desforges J.F., Conn P.M., Crowley W.F. Gonadotropin-Releasing Hormone and Its Analogues. N. Engl. J. Med. 1991;324:93–103. doi: 10.1056/NEJM199101103240205. - DOI - PubMed

Publication types

LinkOut - more resources